awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36266471-247B99D8-466F-4D27-8CCA-E1DF359737DB
Q36266471-247B99D8-466F-4D27-8CCA-E1DF359737DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36266471-247B99D8-466F-4D27-8CCA-E1DF359737DB
Role of disease risk scores in comparative effectiveness research with emerging therapies
P2860
Q36266471-247B99D8-466F-4D27-8CCA-E1DF359737DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36266471-247B99D8-466F-4D27-8CCA-E1DF359737DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc0aa3fcaed88fca15ed5cca1cad15260eb0361f
P2860
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R